ArticleRheumatology advances in practice2026
Litigation trends within rheumatology: a retrospective analysis of claims data from England for the Getting It Right First Time programme.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To examine rheumatology-related litigation claims over a 5-year period to describe trends and identify learning opportunities. Methods: Data were extracted from NHS Resolution for all claims within rheumatology or claims referencing 'giant cell arteritis (GCA)' or 'vasculitis' within any specialty over 5 years (2018/19-2022/23). Variables for each claim included cause, injury, costs and claim status. Results: We identified 152 rheumatology claims (total cost £28.2 million). The most frequent injuries were unnecessary pain [ Conclusions: High-cost, high-harm claims persist in rheumatology, with most remaining open for several years, creating personal, financial and professional strain. GCA-related claims are increasing and occur mostly outside rheumatology, highlighting the need for pan-speciality awareness agreed-upon care pathways. RAIRD-related claims seemed overrepresented in cases of fatality, highlighting the importance of timely suspicion, close monitoring and careful management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.